Return to program book search
Medical Management of Actinic Keratoses and Non-Melanoma Skin Cancer
Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.
Friday, August 17
3:00 PM - 5:00 PM
Neal D. Bhatia, MD, FAAD - Handout
Following this course, the attendee should be able to:
- Categorize and compare the mechanisms of action of therapeutics as they apply to the mechanisms of photodamage and carcinogenesis.
- Summarize data from recent clinical trials and studies comparing efficacy and potential applications for medical management as adjuncts or alternatives to surgery for skin cancer.
- Identify new and emergent therapies for the treatment of advanced skin cancer and chemoprevention of skin cancer.
There have been many new developments in the therapeutic options for medical management of skin cancer, and it is the responsibility of dermatologists to be aware of their mechanisms of action, potential applications, and placement in the clinical setting to best serve patients. The goals of the session are to provide insight to the existing and new therapies in terms of their roles and purposes, review clinical trial data as well as new studies and research, and explore the options in the dermatology marketplace of new approaches to advanced disease and application of chemoprevention in daily patient care.
|Friday, August 17|
|3:00 PM||Review of Disease Progression and Mechanisms of Action of Therapy / Dr. Bhatia|
|3:20 PM||Clinical Trials Update and Practical Combination Therapies / Dr. Del Rosso|
|3:40 PM||Photodynamic Therapy and Medical Management / Dr. Tsoukas|
|4:00 PM||New Advances in Medical Management of NMSC / Torres|
|4:20 PM||Case Discussions / All faculty|
|4:40 PM||Questions & Answers / All faculty|